Using behavioral data to improve mental health treatment outcomes
Phenotypes REimagined to Define Clinical Treatment and Outcome Research (PREDiCTOR)
This study is looking at how we can use information from your conversations and smartphone habits to better understand and support young people with mental health challenges, helping to predict when someone might need extra care or support.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11136982 on NIH RePORTER |
What this research studies
This research investigates how to enhance clinical decision-making in psychiatry by utilizing behavioral data collected during clinical interviews and from smartphones. By analyzing spoken language, eye contact, and other non-verbal cues, along with smartphone metrics like physical activity and sleep patterns, the study aims to create individualized clinical signatures. These signatures will help predict treatment disengagement and hospitalizations among young individuals seeking mental health support. The goal is to provide more reliable prognoses and improve treatment strategies for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are young individuals aged 15 to 30 who are seeking mental health treatment.
Not a fit: Patients outside the age range of 15 to 30 or those not seeking mental health treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective mental health treatments for young patients.
How similar studies have performed: Previous research has shown promise in using behavioral data for clinical decision-making, indicating that this approach could be effective.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Kahn, Rene S. — Icahn School of Medicine at Mount Sinai
- Study coordinator: Kahn, Rene S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.